A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer - Kiemeney, Lambertus A; Sulem, Patrick; Besenbacher, Soren; Vermeulen, Sita H; Sigurdsson, Asgeir; Thorleifsson, Gudmar; Gudbjartsson, Daniel F; Stacey, Simon N; Gudmundsson, Julius; Zanon, Carlo; Kostic, Jelena; Masson, Gisli; et al. (Nature genetics, 2010)
Keywords: 631/208/69; 631/208/727/2000; 631/208/737; 692/699/67/589/1336; Agriculture; Alleles; Animal Genetics and Genomics; Biological and medical sciences; Biomedical and Life Sciences; Biomedicine; Bladder cancer; Cancer; Cancer and Oncology; Cancer och onkologi; Cancer Research; Chromosomes; Chromosomes, Human, Pair 4; Disease-Free Survival; Europe; Female; Fibroblast Growth Factor; Fundamental and applied biological sciences. Psychology; Gene Function; Genetic; Genetic aspects; Genetic Predisposition to Disease; Genetic susceptibility; Genetic Variation; genetics; Genetics of eukaryotes. Biological and molecular evolution; Genotype; Human; Human Genetics; Humans; letter; Male; Medical research; Medical sciences; Models, Genetic; Mutation; Nephrology. Urinary tract diseases; Pair 4; Receptor; Receptor, Fibroblast Growth Factor, Type 3 - genetics; Recurrence; Risk; Risk factors; Smoking; Tumors; Tumors of the urinary system; Type 3; Urinary bladder; Urinary Bladder Neoplasms; Urinary Bladder Neoplasms - genetics; Urinary system involvement in other diseases. Miscellaneous; Urinary tract. Prostate gland; Europe; United Kingdom; Germany; Spain; Variant; Urinary system disease; Bladder disease; Urinary tract disease; Malignant tumor; Bladder cancer; Cancer